| Reconsidering the family history in primary care EC Rich, W Burke, CJ Heaton, S Haga, L Pinsky, MP Short, L Acheson Journal of general internal medicine 19 (3), 273-280, 2004 | 410 | 2004 |
| Public knowledge of and attitudes toward genetics and genetic testing SB Haga, WT Barry, R Mills, GS Ginsburg, L Svetkey, J Sullivan, ... Genetic testing and molecular biomarkers 17 (4), 327-335, 2013 | 274 | 2013 |
| Primary care physicians' knowledge of and experience with pharmacogenetic testing SB Haga, W Burke, GS Ginsburg, R Mills, R Agans Clinical genetics 82 (4), 388-394, 2012 | 272 | 2012 |
| Genomic profiling to promote a healthy lifestyle: not ready for prime time SB Haga, MJ Khoury, W Burke Nature genetics 34 (4), 347-350, 2003 | 179 | 2003 |
| Ethical, legal, and social implications of biobanks for genetics research SB Haga, LM Beskow Advances in genetics 60, 505-544, 2008 | 175 | 2008 |
| Survey of US public attitudes toward pharmacogenetic testing SB Haga, JM O'Daniel, GM Tindall, IR Lipkus, R Agans The pharmacogenomics journal 12 (3), 197-204, 2012 | 155 | 2012 |
| Handbook of human tissue sources: a national resource of human tissue samples E Eiseman, S Haga Rand, 1999 | 144 | 1999 |
| Impact of limited population diversity of genome-wide association studies SB Haga Genetics in Medicine 12 (2), 81-84, 2010 | 123 | 2010 |
| Insurance coverage policies for personalized medicine A Hresko, SB Haga Journal of Personalized Medicine 2 (4), 201-216, 2012 | 110 | 2012 |
| Primary care physicians’ knowledge, attitudes, and experience with personal genetic testing SB Haga, E Kim, RA Myers, GS Ginsburg Journal of personalized medicine 9 (2), 29, 2019 | 103 | 2019 |
| BP1, a new homeobox gene, is frequently expressed in acute leukemias SB Haga, S Fu, JE Karp, DD Ross, DM Williams, WD Hankins, F Behm, ... Leukemia 14 (11), 1867-1875, 2000 | 90 | 2000 |
| Clinical delivery of pharmacogenetic testing services: a proposed partnership between genetic counselors and pharmacists R Mills, SB Haga Pharmacogenomics 14 (8), 957-968, 2013 | 86 | 2013 |
| Public perspectives on returning genetics and genomics research results J O’daniel, SB Haga Public health genomics 14 (6), 346-355, 2011 | 84 | 2011 |
| Developing patient-friendly genetic and genomic test reports: formats to promote patient engagement and understanding SB Haga, R Mills, KI Pollak, C Rehder, AH Buchanan, IM Lipkus, JH Crow, ... Genome medicine 6, 1-11, 2014 | 83 | 2014 |
| Genomic risk profiling: attitudes and use in personal and clinical care of primary care physicians who offer risk profiling SB Haga, MM Carrig, JM O’Daniel, LA Orlando, LA Killeya-Jones, ... Journal of General Internal Medicine 26, 834-840, 2011 | 79 | 2011 |
| The potential impact of pharmacogenetic testing on medication adherence SB Haga, NMA LaPointe The pharmacogenomics journal 13 (6), 481-483, 2013 | 77 | 2013 |
| Translating genomic biomarkers into clinically useful diagnostics GS Ginsburg, SB Haga Expert review of molecular diagnostics 6 (2), 179-191, 2006 | 77 | 2006 |
| BP1, a homeodomain-containing isoform of DLX4, represses the β-globin gene MB Chase, S Fu, SB Haga, G Davenport, H Stevenson, K Do, D Morgan, ... Molecular and cellular biology, 2002 | 77 | 2002 |
| Managing incidental genomic findings: legal obligations of clinicians EW Clayton, S Haga, P Kuszler, E Bane, K Shutske, W Burke Genetics in Medicine 15 (8), 624-629, 2013 | 76 | 2013 |
| Pharmacogenetic testing: not as simple as it seems SB Haga, W Burke Genetics in Medicine 10 (6), 391-395, 2008 | 76 | 2008 |
